Previous Article | Next Article 
Infection and Immunity, August 2000, p. 4725-4735, Vol. 68, No. 8
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Antigenic and Sequence Diversity in Gonococcal
Transferrin-Binding Protein A
Cynthia Nau
Cornelissen,1,*
James E.
Anderson,2
Ian C.
Boulton,1,
and
P.
Frederick
Sparling2,3
Department of Microbiology and Immunology,
School of Medicine, Virginia Commonwealth University, Richmond,
Virginia 23298,1 and Departments of
Medicine2 and Microbiology and
Immunology,3 School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599
Received 10 March 2000/Returned for modification 21 April
2000/Accepted 12 May 2000
 |
ABSTRACT |
Neisseria gonorrhoeae is a gram-negative pathogen that
is capable of satisfying its iron requirement with human iron-binding proteins such as transferrin and lactoferrin. Transferrin-iron utilization involves specific binding of human transferrin at the cell
surface to what is believed to be a complex of two iron-regulated, transferrin-binding proteins, TbpA and TbpB. The genes encoding these
proteins have been cloned and sequenced from a number of pathogenic,
gram-negative bacteria. In the current study, we sequenced four
additional tbpA genes from other N. gonorrhoeae
strains to begin to assess the sequence diversity among gonococci. We
compared these sequences to those from other pathogenic bacteria to
identify conserved regions that might be important for the structure
and function of these receptors. We generated polyclonal mouse sera against synthetic peptides deduced from the TbpA sequence from gonococcal strain FA19. Most of these synthetic peptides were predicted
to correspond to surface-exposed regions of TbpA. We found that, while
most reacted with denatured TbpA in Western blots, only one antipeptide
serum reacted with native TbpA in the context of intact gonococci,
consistent with surface exposure of the peptide to which this serum was
raised. In addition, we evaluated a panel of gonococcal strains for
antigenic diversity using these antipeptide sera.
 |
INTRODUCTION |
Virtually all microorganisms require
iron as a cofactor for various enzymatic processes (8).
Because free iron concentrations are low in oxygenated environments at
neutral pH (44) and in plant and animal hosts
(55), microbes have evolved intricate and elegant mechanisms
by which they scavenge iron from their surroundings. The most common
method involves the synthesis of siderophores, which bind iron with
high affinity and specificity (44). The process of iron
utilization via a siderophore intermediate requires specific binding of
the ferric siderophore to a surface-exposed receptor (for reviews, see
references 7 and 43). Energy is provided to these TonB-dependent receptors in the form of the proton
motive force through the function of an energy-transducing complex of
proteins, TonB, ExbB, and ExbD (28, 30, 48).
As an alternative to siderophore synthesis, some bacteria have evolved
the capacity to utilize host-derived iron sources by a direct,
receptor-mediated mechanism, which is uniquely adapted to the
organism's preferred host (for reviews, see references 18 and 24). For example,
Actinobacillus pleuropneumoniae, a porcine pathogen,
specifically utilizes iron from porcine transferrin (21),
whereas Neisseria gonorrhoeae, a strict human pathogen, binds and utilizes the iron specifically from human transferrin (5, 33). N. gonorrhoeae and its close relative
Neisseria meningitidis also utilize iron bound to human
lactoferrin, hemoglobin, and heme (39). Binding of
transferrin, lactoferrin, and hemoglobin to the pathogenic members of
the family Neisseriaceae involves two characterized
proteins, one of which bears a resemblance to TonB-dependent,
siderophore receptors and the other of which is lipidated (1, 3,
4, 6, 15, 34, 35, 47, 54). In the transferrin-iron
internalization system, these two proteins have been designated TbpA
and TbpB, respectively. A gonococcal mutant lacking both TbpA and TbpB
was unable to establish an infection or elicit signs or symptoms of
urethritis in a human challenge model of gonococcal infection
(16). Although this result strongly implicates the function
of the gonococcal transferrin receptor in the initial stages of
gonococcal disease, it should be noted that both the tbp
mutant and the wild-type strain (FA1090) used in this study were
incapable of lactoferrin-iron utilization. Anderson and Sparling have
recently created a lactoferrin-positive, transferrin-negative
derivative of FA1090 and are currently testing this mutant in the human
challenge model to elucidate the role of the lactoferrin receptor in
the initiation of urethritis in human males (unpublished data).
Sequence analysis and functional studies of the transferrin receptors
(for reviews, see references 14 and
18) have led to the hypothesis that TbpA and TbpB
constitute the functional transferrin receptor, which serves as the
first point of contact between ferrated transferrin and the bacterium.
We have suggested that TbpB increases the efficiency of iron uptake
from transferrin by virtue of its specificity for the ferrated ligand
(1, 17). Because TbpA is similar to other TonB-dependent
receptors, we have proposed that it forms the pore through which
transferrin-bound iron enters the periplasm (15, 18). Recent
crystal structures of two other TonB-dependent receptors (10,
37) described two functional domains within these outer membrane
receptors. The first domain represents the amino-terminal third of the
protein and includes the so-called TonB box (53), which has
been implicated in a physical association between TonB and outer
membrane receptors (2, 27, 32, 52). In addition to the TonB
box, this amino-terminal domain contains two other regions that are
conserved among TonB-dependent receptors (15). The crystal
structures of FepA and FhuA locate this amino-terminal domain not
within the plane of the membrane, as previous models suggested
(31, 41), but within the lumen of the
-barrel formed by
the remaining two-thirds of the protein. This "plug"
(37) or internal "hatch" (10) is postulated
to limit access into the periplasm and opens only when it
simultaneously senses the presence of ligand and cytoplasmic
membrane-derived energy.
The neisserial transferrin receptor is subject to intense scrutiny not
only to ascertain its mode of operation but also because both
components have become viable vaccine candidates for immunoprophylaxis against both meningococcal and gonococcal disease. The transferrin receptors expressed by N. meningitidis strains have been
grouped into two distinct classes based on molecular weight and
sequence heterogeneity (49). Most strains fall into the
high-molecular-weight class, while approximately a quarter of the
strains tested expressed a version of TbpB that was significantly
smaller. Among a panel of 50 gonococcal strains, all express a TbpB
that is closely related to the high-molecular-weight class of
meningococcal TbpBs; there is no evidence of a low-molecular-weight
species of gonococcal TbpB (13). The purpose of the current
study was to begin to assess the antigenic and sequence variability of
TbpA species among gonococcal strains, which is a necessary step in the
evaluation of TbpA as a potential vaccine component. We sequenced four
new gonococcal tbpA genes and compared them to our
previously published gonococcal tbpA sequence. We also
compared the gonococcal TbpAs with those from N. meningitidis, Haemophilus influenzae, A. pleuropneumoniae, Moraxella catarrhalis, and
Pasteurella haemolytica. Sequence variability among
gonococcal TbpAs is likely to be highly represented in surface-exposed regions, while sequence conservation among diverse TbpAs might indicate
regions that are structurally or functionally constrained. We generated
a set of antipeptide sera directed at putatively surface-exposed
regions of gonococcal TbpA, which we used to assess the antigenic
diversity within a larger group of gonococcal strains. We found that,
while most of the antipeptide sera reacted with denatured TbpA, only
one serum recognized membrane-bound TbpA, suggesting that the epitope
to which this serum was raised was surface exposed in the gonococcus.
 |
MATERIALS AND METHODS |
Strains and growth conditions.
The gonococcal strains used
in this study are described in Table 1.
Gonococci were maintained on Bacto GC medium base (Difco) to which
Kellogg's supplement I (29) and 12 µM
Fe(NO3)3 were added. Plates were incubated at
35°C in a 5% CO2 atmosphere. To induce iron stress,
gonococci were grown in CDM medium (56), to which either no
iron or 30% iron-saturated, human transferrin (2.5 µM) (Sigma
Aldrich Chemicals, St. Louis, Mo.) was added. In other experiments,
iron stress was induced by growth of gonococci on GC medium base
plates, to which 10 µM deferoxamine mesylate (Sigma Aldrich
Chemicals) was added in place of the Fe(NO3)3
supplement.
Molecular biological procedures.
Primers designed to PCR
amplify all or portions of tbpA genes from FA1090, UU1008,
Pgh3-2, and 4102 chromosomal DNA preparations are as follows. Primers
JRW2 (5'-CCAAGGCGAGCGCACCGATG-3') and TfBP1
(5'-GAGCCCGCCAATGCGCCGCT-3') were used to amplify the 5' portion of tbpA, while TfBP27
(5'-CGGTGTATCGGGAAGGATGG-3') and TfBP34
(5'-GTCGAAATCAGCAAAGGC-3') were used to amplify the 3' portion of the gene. In other experiments, we used Hind
(5'-CGAAGAGTTGGGCGGATGGTT-3') and oVCU-7
(5'-CTCGAGGCTCTAGAAACCCCAACGCAG-3') primers to amplify tbpA in its entirety. PCR products were purified by agarose
gel electrophoresis using Magic PCR columns (Promega, Madison, Wis.) and cloned into the pCRII vector (InVitrogen, San Diego, Calif.). Pools
of 6 to 10 clones for each PCR product were used as sequencing templates. In some cases, PCR products were not cloned but pooled and
sequenced directly. Manual sequencing was performed using Sequenase
(United States Biochemical Corporation, Cleveland, Ohio), and automated
sequencing was performed at the University of North Carolina at Chapel
Hill Automated DNA Sequencing Facility on a Model 373A DNA Sequencer
(Applied Biosystems, Foster City, Calif.) using a Taq
DyeDeoxy Terminator Cycle sequencing kit (Applied Biosystems). Both
strands of the PCR products were sequenced in both directions using
specific primers designed from the FA19 tbpA sequence or
using vector-specific primers. Sequence analysis was performed using
the University of Wisconsin GCG software package (Madison, Wis.)
(19). Alignments of the TbpA sequences were constructed from
sequences listed in Table 2 using the
programs PILEUP and PRETTY. The relatedness tree was constructed using the alignment created by PILEUP and the program GROWTREE.
Antipeptide sera.
Eight peptides of 11 to 14 residues in
length were synthesized with the sequences highlighted in green in Fig.
1. These peptides were predicted to be
hydrophilic, antigenic, and surface exposed by the
program PLOTSTRUCTURE (Genetics Computer Group, Inc.,
Madison, Wis.). Peptides were conjugated to Pierce's SuperCarrier
according to the manufacturer's recommendations (Pierce, Rockford,
Ill.). For each peptide conjugate, five mice were immunized
subcutaneously in Freund's complete adjuvant and two subsequent times
in Freund's incomplete adjuvant. Mice were exsanguinated 12 weeks
after the first immunization. Sera from individual mice were maintained separately and screened individually.



View larger version (280K):
[in this window]
[in a new window]
|
FIG. 1.
Multiple sequence alignment of TbpA proteins. The letter
preceding the sequence name to the left of each line indicates the
species from which the TbpA sequence was derived: a, N. gonorrhoeae; b, N. meningitidis; c, M. catarrhalis; d, H. influenzae; e, A. pleuropneumoniae; f, P. haemolytica. Boxed
single-letter amino acid designations indicate the mature amino
terminus of TbpA, if known. Sequences highlighted in green represent
the gonococcal strain FA19 TbpA sequences that were synthesized as
peptides to generate antipeptide sera. These peptides are numbered and
labeled TbpA-1 through TbpA-8, consecutively, from amino terminus to
carboxy terminus. Yellow highlighting represents regions homologous to
known transmembrane -strands in E. coli FepA. Blue
shading signifies diversity among TbpAs from five gonococcal strains.
Gray shading indicates residues that are unique to TbpAs expressed by
the human pathogens. Cysteine residues are highlighted in orange. The
black vertical arrow represents the carboxy-terminal end of the
so-called plug region, defined by homology with E. coli
FepA. Dots indicate positions in which gaps were introduced in the
alignment; squiggles indicate positions for which no sequence was
available. In the consensus line, the asterisks represent complete
identity among all 17 aligned sequences; plus signs indicate
conservative replacements at that position in the 17-sequence
alignment.
|
|
Characterization of antipeptide sera.
Sera obtained
following immunizations were screened by Western blotting against
whole-cell lysates of gonococcal strains FA19 and FA6815 as previously
described (13). Those sera that were negative by Western
blotting for reactivity against wild-type TbpA were screened by
enzyme-linked immunosorbent assay (ELISA) against homologous peptide.
Dilutions of purified peptide were applied to ReactiBind plates
(Pierce) according to the manufacturer's recommendations. Dilutions of
preimmune sera and hyperimmune sera were screened for reactivity with
each peptide by standard procedures. All sera were screened for
reactivity against whole-cell dot blots of gonococcal strains FA19 and
FA6815 essentially as previously described for solid-phase, transferrin
binding assays (17). Bound polyclonal mouse antibodies were
detected by addition of a secondary goat anti-mouse immunoglobulin G
conjugated to alkaline phosphatase (Sigma Aldrich) followed by
development with nitroblue tetrazolium and BCIP
(5-bromo-4-chloro-3-indolylphosphate). Immunofluorescence microscopy
was performed to verify that antiserum against peptide TbpA-5 bound to
surface-exposed epitopes of TbpA on intact gonococci. Iron-stressed,
whole cells from gonococcal strains FA19 and FA6747 were mixed with
dilutions of preimmune and hyperimmune sera along with
immunoglobulin-free bovine serum albumin (Sigma Aldrich) as a
nonspecific blocker. Unbound antibody was removed by centrifugation, and then cells with bound antibody were applied to glass microscope slides and immersed in 100% methanol for fixation. Subsequently, slides were probed with a secondary goat anti-mouse antibody conjugated to fluorescein isothiocyanate (Sigma Aldrich) and cells were
counterstained with Eriochrome Black (Integrated Diagnostics,
Baltimore, Md.). Samples were visualized in an Olympus BHA microscope
equipped with a model BH2RFL reflected fluorescence attachment and a
model PM-10AD photomicrographic system (Olympus Corp., Melville, N.Y.). Negative controls in these experiments included probing FA6747 (TbpA
) with antiserum against peptide TbpA-5 and probing
FA19 with preimmune sera. The positive control was FA19 probed with an
antiserum raised against gonococcal PorA.
Nucleotide sequence accession numbers.
The DNA sequences
determined in this study were reported to the GenBank database under
the accession numbers listed in Table 2.
 |
RESULTS |
DNA sequence analysis of tbpA from four gonococcal
strains.
The sequences of four gonococcal tbpA genes
were determined to begin to assess the extent of interstrain genetic
variability of this potential vaccine antigen. The predicted protein
sequence of TbpA from gonococcal strain UU1008 was 95.1% identical to
the published TbpA sequence (15) from strain FA19, while the
TbpA sequence from FA1090 was 96.2% identical to the FA19 TbpA
sequence (Table 3). The FA1090 TbpA
sequence determined in this study was identical to that identified in
the nearly complete, gonococcal genome sequencing project (B. A. Roe, S. P. Lin, L. Song, X. Yuan, S. Clifton, T. Ducey, L. Lewis,
and D. W. Dyer, Gonococcal Genome Sequencing Project
[http://www.genome.ou.edu/gono.html]). TbpAs from gonococcal strains
4102 and Pgh3-2 were likewise very similar to that of FA19, sharing
96.1 and 97.4% identity, respectively. All of the gonococcal TbpA
sequences were closely related to the TbpA sequences from meningococcal
strains M982 and B:15, P1.16; pairwise identity scores for these two
meningococcal proteins compared with the gonococcal TbpAs ranged from
93.5 to 95.1% (Table 3). In contrast, the TbpA sequence from
meningococcal strain B16B6 exhibited only 75.9 to 77% identity
compared to the other neisserial TbpAs (Table 3). Thus, all of the
gonococcal TbpA sequences determined to date closely resemble the TbpA
sequences from meningococcal strains M982 and B:15, P1.16. Figure 1
depicts a multiple sequence alignment comparing the neisserial TbpA
proteins determined in this study with those available in GenBank
(Table 2). The residues highlighted in blue depict those that are
variant among the gonococcal TbpAs. These residues appear in clusters highlighting four hypervariable domains, which correspond to residues 269 to 332, 412 to 447, 583 to 743, and 912 to 929 in the alignment in
Fig. 1.
Comparison between gonococcal TbpAs and TbpAs from other
genera.
We also compared the gonococcal TbpA sequences determined
in this study with those available in GenBank for H. influenzae, A. pleuropneumoniae, M. catarrhalis, and P. haemolytica (Table 2). Identical
residues in all 17 aligned sequences (Fig. 1) are indicated by an
asterisk in the consensus line, while conserved residues are indicated
by a plus sign. Due to their maintenance across genera, these conserved
residues are likely to be constrained by the common function, topology,
or assembly of these transferrin receptors. Most of the conservation
among these proteins was confined to narrow domains that are virtually
superimposable with hypothetical transmembrane
-strands (highlighted
in yellow in Fig. 1). These putative
-strands were identified by
constructing a pairwise alignment between gonococcal TbpA and the
Escherichia coli ferric enterobactin receptor, FepA, for
which the crystal structure has been determined previously
(10). Two other features of TbpA were conserved across genus
lines. These included six paired cysteine residues (orange in Fig. 1),
which are likely to be located in surface-exposed loops (10, 37,
51), and a 209-residue, amino-terminal domain, which is
homologous to the so-called plug or hatch identified in the E. coli TonB-dependent receptors (between the amino terminus and the
vertical arrow in Fig. 1). This amino-terminal region not only is well
conserved among the 17 sequences aligned in Fig. 1 but also contained
three of the seven characterized domains that are shared by all
TonB-dependent proteins (15).
Pairwise identity scores between neisserial TbpAs and TbpAs expressed
by other genera ranged from 43% in P. haemolytica to 52.6%
in H. influenzae (Table 3). Using these pairwise identity scores, we generated the relatedness tree of TbpA proteins shown in
Fig. 2. This tree reflects the
relationship between TbpAs expressed by different genera and species;
it does not necessarily reflect the overall genetic relatedness between
these organisms. Of particular note was the early branching between the
TbpAs expressed by the animal pathogens (A. pleuropneumoniae
and P. haemolytica) and by the human pathogens. TbpAs
expressed by M. catarrhalis strains branched off next,
followed by those expressed by H. influenzae strains. The
phylogram in Fig. 2 also emphasizes the genetic distance between the
TbpA from meningococcal strain B16B6 and the rest of the neisserial
TbpAs.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
Relatedness tree of TbpA proteins. The letter preceding
the sequence name indicates the species from which the TbpA sequence
was derived: a, N. gonorrhoeae; b, N. meningitidis; c, M. catarrhalis; d, H. influenzae; e, A. pleuropneumoniae; f, P. haemolytica. The scale bar at the bottom represents 10 substitutions per 100 residues.
|
|
Reactivities of antipeptide sera.
We initially generated
antiserum against eight peptides to test our hypothetical topology
model of gonococcal TbpA (I. C. Boulton, M. K. Yost, J. E. Anderson, and C. N. Cornelissen, submitted for publication). Peptides
were synthesized with the sequences shown in Fig. 1 and were chosen
because they were hydrophilic and predicted to be surface exposed and
antigenic, with the exception of peptides TbpA-1 and TbpA-2, which were
chosen as negative controls in surface exposure experiments.
Antipeptide sera were raised in mice and screened by Western blotting
against iron-stressed, whole-cell lysates prepared from the wild-type
strain and from an isogenic tbpA mutant. Sera elicited
against peptides TbpA-2, TbpA-3, TbpA-5, and TbpA-6 recognized TbpA
specifically in this assay (Fig. 3).
Those sera that were negative by Western blotting were screened by
ELISA to determine whether the peptide elicited an immune response. All
sera reacted against homologous peptide in an ELISA format, although
the anti-TbpA-1 serum did so weakly and thus was not further
characterized. These results indicated that antibodies elicited against
peptides TbpA-1, TbpA-4, TbpA-7, and TbpA-8, while not reactive against
full-length TbpA, were capable of recognizing the immunizing peptide.

View larger version (103K):
[in this window]
[in a new window]
|
FIG. 3.
Antigenic heterogeneity among gonococcal TbpA proteins.
The Western blot contains iron-stressed, whole-cell lysates from the
following gonococcal strains: FA19, FA1090, UU1008, Pgh3-2, and FA6642
(lanes 1 to 5, respectively). Lanes 6 to 13 contain lysates from the
following gonococcal strains obtained from R. Brunham: 4102, 4121, 4125, 4141, 4146, 4178, 4196, and 4134, respectively. Lane 14 contains
an iron-stressed, whole-cell lysate from meningococcal strain FAM20.
Blots were probed with antisera raised against TbpA-specific peptides
as indicated at right. Blots were scanned with an HP ScanJet 4c and
annotated with Adobe Photoshop 4.0 software.
|
|
All antipeptide sera, with the exception of that raised against TbpA-1,
were screened by whole-cell dot blotting for reactivity against whole,
iron-stressed gonococci (Fig. 4). The
only serum that specifically reacted in this assay format was raised
against peptide TbpA-5 (Fig. 4). Due to the tendency of gonococci to
lyse, which could result in apparent surface exposure in dot blots, we
confirmed the dot blot result using immunofluorescence microscopy, in
which the integrity of the reactive organisms could be assessed by
counterstain. As in the dot blot experiment, antiserum raised against
TbpA-5 was reactive by this technique against whole, iron-stressed TbpA-expressing gonococci but not against an isogenic tbpA
mutant (data not shown). These results indicated that the loop
containing peptide TbpA-5 was surface exposed. Counter to our original
hypothesis, antiserum raised against the other peptides did not react
with whole gonococci (Fig. 4), even though peptides TbpA-3, TbpA-4, TbpA-6, TbpA-7, and TbpA-8 represented epitopes that were predicted to
be surface exposed. These sera were likewise not reactive against TbpA
expressed by FA6819 in the absence of TbpB (data not shown); thus, the
epitopes represented by these peptides were not simply masked by the
presence of TbpB. However, it is possible that lipooligosaccharide or
some other surface structure could obstruct access by antibody to TbpA
even if the peptide-containing epitopes are on the surface.

View larger version (64K):
[in this window]
[in a new window]
|
FIG. 4.
Binding of antipeptide sera to whole, iron-stressed
gonococcal cells. All strains tested in this analysis were derivatives
of gonococcal strain FA19. Columns of spots contain whole,
iron-stressed cells (C) or total membrane preparations (M) of strain
FA19 or FA6747, as indicated at top. Rows of spots were probed with
preimmune mouse serum (P) or hyperimmune serum (I) from mice immunized
with peptides TbpA-2 through TbpA-8, as indicated on either side of the
blot. Spots in the lower right corner of the blot (labeled anti-Por)
were probed with a PorA monoclonal antibody as a positive control. The
blot was scanned with an HP ScanJet 4c and annotated with Adobe
Photoshop 4.0 software.
|
|
Using antipeptide sera to assess antigenic variability among
gonococci.
A panel of 13 gonococcal strains and one meningococcal
strain (representative of the low-molecular-weight class) was screened for reactivity with the four Western blot-positive antipeptide sera. As
noted previously (13), molecular mass heterogeneity of TbpA
among gonococci is limited to between 100 and 103 kDa (Fig. 3). All 13 gonococcal strains expressed a TbpA that reacted with two of the
antipeptide sera, those elicited against TbpA-2 and TbpA-6 (Fig. 3).
This result suggested that the epitopes represented by these two
peptides were well conserved among the gonococcal strains tested. Sera
against peptide TbpA-3 reacted with TbpA from 2 out of 13 gonococcal
strains, while sera against TbpA-5 reacted with TbpA expressed by 6 out
of 13 strains tested. None of the antipeptide sera reacted with the
low-molecular-weight TbpA expressed by meningococcal strain FAM20 (Fig.
3, lane 14). These observations are consistent with the sequence
heterogeneity depicted in Fig. 1 in that the regions containing
peptides TbpA-3 and TbpA-5 were more variable than those containing
peptides TbpA-2 and TbpA-6.
 |
DISCUSSION |
Since the transferrin-binding proteins have been touted as
potential components of a vaccine (36, 50), it is important to assess their interstrain antigenic and sequence variation in addition to defining topology and surface exposure. Gonococcal TbpBs
(13) are more diverse than gonococcal TbpAs; however, they
do not share the great diversity found among meningococcal TbpBs
(49). Meningococcal TbpBs fall into two distinct classes based on molecular mass and sequence characteristics. The
low-molecular-weight family, consisting of approximately 26% of tested
strains represented by strain B16B6, expresses a TbpB protein of 68 kDa, while the high-molecular-weight family, represented by strain
M982, expresses a TbpB of 85 kDa (49). All tested gonococcal
strains express a TbpB with M982-like characteristics; there is no
evidence of a B16B6-type TbpB (13). In the current study, we
assessed the sequence variability of gonococcal TbpAs and found that
they are very similar to each other and equally similar to TbpAs of
meningococcal strains in the M982 family. In contrast, gonococcal TbpAs
share only 75% identity with the TbpA expressed by meningococcal
strain B16B6. This observation suggests that both TbpB and TbpA
proteins expressed by B16B6-type meningococcal strains are distinct
from those expressed by the M982 family. That is, both
transferrin-binding proteins can be categorized into either high- or
low-molecular-weight classes; meningococcal strain B16B6, as the
representative of the low-molecular-weight class for which the
sequences of TbpA and TbpB are known, expresses a 68-kDa TbpB protein
and a distinct, although not markedly smaller, TbpA protein.
Sequence diversity among gonococcal TbpAs was largely confined to four
small regions that could be defined as hypervariable domains, by
analogy with other neisserial antigens (12, 25, 26). Two of
the four hypervariable domains were in the vicinity of paired cysteine
residues in gonococcal TbpA, again reminiscent of another gonococcal
antigen, pilin. In gonococcal pilin, a characterized hypervariable
region, also known as minicassette 2, is flanked by conserved cysteine
residues (25). In addition to sequence variation, regions
interspersed between putative transmembrane domains also contain all of
the length diversity detected by aligning 17 TbpA sequences from a wide
array of bacterial pathogens. The presence of both length and sequence
variation in these areas is consistent with their topological
assignment as either internal or external putative loops. Two of the
antipeptide sera generated in this study detected only a subset of
gonococcal TbpAs. Consistent with this observation, the sequences
against which these sera were raised lie within the above-defined
hypervariable regions. This suggests that TbpA-specific peptide
antisera could be used for serotyping, in a manner similar to those
utilized currently in porin-specific serotyping schemes.
Stretches of sequence conservation among TbpAs are likely to represent
domains of the protein that are constrained by common function or
localization. In our alignment of 17 TbpAs, the majority of sequence
identity was found within or slightly outside of regions that are
homologous to characterized transmembrane
-strands in E. coli FepA (10). Strikingly, none of the putative TbpA
transmembrane domains contains any length diversity, suggesting that
maintenance of both length and sequence identity is required for the
structure and/or function of these receptors. Other pockets of
conservation include the putative plug region, which is not only
conserved among TbpAs but also well conserved among all members of the
TonB-dependent receptor family (10). Six cysteine residues
were also conserved among all TbpAs analyzed, although the distance
between the first and second cysteine residues varied. Two pairs of
cysteine residues were flanked by hypervariable residues; in contrast,
the third set of cysteines was flanked by residues that were conserved
among the gonococci. Although all of the cysteine residues are likely to reside in extracellular loops (10, 37, 51), it is unclear why some are within apparent hypervariable regions while others are
flanked by conserved residues. Of note is the presence of a unique pair
of cysteine residues in P. haemolytica TbpA that coincides
with one of the four hypervariable regions. The presence of this pair
of cysteine residues strengthens our hypothesis that this hypervariable
region (containing peptide TbpA-7) is located in an extracellular loop.
By focusing on the putative loop regions interspersed between the
transmembrane strands, we can identify several regions that are
distinct between the TbpAs expressed by the human pathogens versus
those expressed by the animal pathogens. These disparities might
highlight epitopes that influence the exquisite species specificity of
these receptors. Thus, residues conserved among the TbpAs of human
pathogens and divergent in the TbpAs of the animal pathogens might be
critical for the specific binding of human transferrin. Residues
highlighted in gray in the alignment in Fig. 1 are unique to the TbpAs
that recognize human transferrin; therefore, these residues might be
critical for this interaction. Alternatively, these residues could be
conserved among the human pathogens because these pathogens are more
closely related and thus the proteins have not had the evolutionary
time to diverge significantly. Another distinction between the TbpAs
expressed by the human and animal pathogens is found in both the length and the sequence of the putative loop located between residues 577 and
758 in the alignment shown in Fig. 1. Excluding the pair of cysteine
residues, this entire putative loop is unique to TbpAs expressed by the
human pathogens. Interestingly, the TbpA sequence of M. catarrhalis features four insertions within this region, adding to
the length diversity of this hypothetically surface-exposed loop. The
plasticity of this region, which also coincides with the ligand-binding
domain of E. coli FepA (45), is consistent with
surface exposure. Camouflaging conserved epitopes with sequence and
length diversity might be important for evasion of an immune response
raised against a receptor that is constrained by the necessity to bind
one ligand. The role, if any, that these differences between the TbpAs
expressed by human and animal pathogens play in receptor specificity
can be tested using current molecular techniques including
site-specific mutagenesis and binding-domain swapping.
We initially generated peptide-specific antisera to probe the topology
of membrane-associated TbpA. The peptides synthesized were hydrophilic
and predicted to be surface exposed and antigenic. While the peptides
generated an immune response, seven out of eight antipeptide sera did
not recognize native TbpA as presented in the context of the gonococcal
outer membrane. The antibodies elicited against peptide TbpA-5
represented the single exception to the poor cross-reactivity between
peptide and native protein epitopes. Antibodies generated against
peptide TbpA-5 recognized both denatured and native TbpA, supporting
the hypothesis that the domain that contains this peptide is surface
accessible on intact gonococci. The reason for the relative lack of
cross-reactivity between the antipeptide sera and native TbpA remains
unclear. The peptides synthesized in this study might have been too
short to adequately mimic the conformation of cell-surface-exposed
TbpA. Alternatively, cyclizing the peptide immunogens could have
increased the frequency with which we obtained sera reactive against
conformational epitopes. While this approach was not particularly
useful for direct topological mapping, the antipeptide sera generated
in this study were helpful in identification of antigenically diverse domains of TbpA. By analogy with other gonococcal antigens, these hypervariable domains are likely to be exposed to the immune system during the course of infection (9). In addition, these
peptide-specific antisera could be useful serotyping reagents since
they highlight antigenic differences among gonococcal strains.
In this study, we compared the sequence and antigenic characteristics
of TbpA from a panel of gonococcal strains. Antigenic and sequence
diversity among gonococcal isolates clustered in hypervariable regions,
which are postulated to be surface exposed in the gonococcus. By
comparing the TbpA proteins expressed by a wide variety of bacterial
pathogens, we identified several conserved regions that are likely to
be confined by the common function and assembly of these receptors.
Many of the conserved domains overlap with areas that are homologous to
transmembrane
-strands in FepA. Other conserved features include the
amino-terminal 209 residues, a sequence which is analogous to the plug
region identified in two crystallized TonB-dependent receptors
(10, 37). Buchanan et al. noted that the structure of this
amino-terminal region was unique among the TonB-dependent receptors and
that the coincidence of conservation and localization suggested that
these domains were crucial for the common function of these receptors
(10). Another conserved feature identified in the current
study of TbpAs was a series of paired cysteine residues, which might be
important for the topological stability of several surface-exposed
loops (10, 37, 51). Our ongoing studies are aimed at
dissection of the surface topology of the transferrin receptor and at
delineation of surface-exposed, antigenic domains of TbpA that might
elicit a cross-reactive, protective immune response.
 |
ACKNOWLEDGMENTS |
This work was supported by Public Health Service grants AI26837
and AI31496 to P.F.S. and AI39523 to C.N.C., both from the National
Institute of Allergy and Infectious Diseases.
We thank Deb Palazzi and Jennifer Watson for excellent technical
assistance. The TbpA-specific peptides were synthesized and conjugated
at ImClone Systems, Inc., New York, N.Y. Immunizations were carried out
at Lederle-Praxis Biologicals in Rochester, N.Y. We also appreciate
assistance from Kate Nowell, Guy Cabral, Marcia Hobbs, and Ann Jerse in
conducting immunofluorescence microscopy experiments.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: P.O. Box 980678, Richmond, VA 23298-0678. Phone: (804) 225-4121. Fax: (804) 828-9946. E-mail: cncornel{at}hsc.vcu.edu.
Present address: Department of Medical Genetics and Microbiology,
University of Toronto, Toronto, Ontario, Canada.
Editor:
D. L. Burns
 |
REFERENCES |
| 1.
|
Anderson, J. E.,
P. F. Sparling, and C. N. Cornelissen.
1994.
Gonococcal transferrin-binding protein 2 facilitates but is not essential for transferrin utilization.
J. Bacteriol.
176:3162-3170[Abstract/Free Full Text].
|
| 2.
|
Bell, P. E.,
C. D. Nau,
J. T. Brown,
J. Konisky, and R. J. Kadner.
1990.
Genetic suppression demonstrates interaction of TonB protein with outer membrane transport proteins in Escherichia coli.
J. Bacteriol.
172:3826-3829[Abstract/Free Full Text].
|
| 3.
|
Biswas, G. D.,
J. E. Anderson,
C.-J. Chen,
C. N. Cornelissen, and P. F. Sparling.
1999.
Identification and functional characterization of the Neisseria gonorrhoeae lbpB gene product.
Infect. Immun.
67:455-459[Abstract/Free Full Text].
|
| 4.
|
Biswas, G. D., and P. F. Sparling.
1995.
Characterization of lbpA, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae.
Infect. Immun.
63:2958-2967[Abstract].
|
| 5.
|
Blanton, K. J.,
G. D. Biswas,
J. Tsai,
J. Adams,
D. W. Dyer,
S. M. Davis,
G. G. Koch,
P. K. Sen, and P. F. Sparling.
1990.
Genetic evidence that Neisseria gonorrhoeae produces specific receptors for transferrin and lactoferrin.
J. Bacteriol.
172:5225-5235[Abstract/Free Full Text].
|
| 6.
|
Bonnah, R. A., and A. B. Schryvers.
1998.
Preparation and characterization of Neisseria meningitidis mutants deficient in production of the human lactoferrin-binding proteins LbpA and LbpB.
J. Bacteriol.
180:3080-3090[Abstract/Free Full Text].
|
| 7.
|
Braun, V.,
K. Gunter, and K. Hantke.
1991.
Transport of iron across the outer membrane.
Biol. Met.
4:14-22[CrossRef][Medline].
|
| 8.
|
Briat, J.-F.
1992.
Iron assimilation and storage in prokaryotes.
J. Gen. Microbiol.
138:2475-2483[Medline].
|
| 9.
|
Brunham, R. C.,
F. A. Plummer, and R. S. Stephens.
1993.
Bacterial antigenic variation, host immune response, and pathogen-host coevolution.
Infect. Immun.
61:2273-2276[Free Full Text].
|
| 10.
|
Buchanan, S. K.,
B. S. Smith,
L. Venkatramani,
D. Xia,
L. Esser,
M. Palnitkar,
R. Chakraborty,
D. van der Helm, and J. Deisenhofer.
1999.
Crystal structure of the outer membrane active transporter FepA from Escherichia coli.
Nat. Struct. Biol.
6:56-63[CrossRef][Medline].
|
| 11.
|
Cohen, M. S.,
J. G. Cannon,
A. E. Jerse,
L. M. Charniga,
S. F. Isbey, and L. G. Whicker.
1994.
Human experimentation with Neisseria gonorrhoeae: rationale, methods, and implications for the biology of infection and vaccine development.
J. Infect. Dis.
169:532-537[Medline].
|
| 12.
|
Connell, T. D.,
D. Shaffer, and J. D. Cannon.
1990.
Characterization of the repertoire of hypervariable regions in the Protein II (opa) gene family of Neisseria gonorrhoeae.
Mol. Microbiol.
4:439-449[CrossRef][Medline].
|
| 13.
|
Cornelissen, C. N.,
J. E. Anderson, and P. F. Sparling.
1997.
Characterization of the diversity and the transferrin-binding domain of gonococcal transferrin-binding protein 2.
Infect. Immun.
65:822-828[Abstract].
|
| 14.
|
Cornelissen, C. N.,
J. E. Anderson, and P. F. Sparling.
1997.
Energy-dependent changes in the gonococcal transferrin receptor.
Mol. Microbiol.
26:25-35[CrossRef][Medline].
|
| 15.
|
Cornelissen, C. N.,
G. D. Biswas,
J. Tsai,
D. K. Paruchuri,
S. A. Thompson, and P. F. Sparling.
1992.
Gonococcal transferrin-binding protein 1 is required for transferrin utilization and is homologous to TonB-dependent outer membrane receptors.
J. Bacteriol.
174:5788-5797[Abstract/Free Full Text].
|
| 16.
|
Cornelissen, C. N.,
M. Kelley,
M. M. Hobbs,
J. E. Anderson,
J. G. Cannon,
M. S. Cohen, and P. F. Sparling.
1998.
The transferrin receptor expressed by gonococcal strain FA1090 is required for the experimental infection of human male volunteers.
Mol. Microbiol.
27:611-616[CrossRef][Medline].
|
| 17.
|
Cornelissen, C. N., and P. F. Sparling.
1996.
Binding and surface exposure characteristics of the gonococcal transferrin receptor are dependent on both transferrin-binding proteins.
J. Bacteriol.
178:1437-1444[Abstract/Free Full Text].
|
| 18.
|
Cornelissen, C. N., and P. F. Sparling.
1994.
Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens.
Mol. Microbiol.
14:843-850[Medline].
|
| 19.
|
Devereux, J.,
P. Haeberli, and O. Smithies.
1984.
A comprehensive set of sequence analysis programs for the VAX.
Nucleic Acids Res.
12:387-395.
|
| 20.
|
Dyer, D. W.,
W. McKenna,
J. P. Woods, and P. F. Sparling.
1987.
Isolation by streptonigrin enrichment and characterization of a transferrin-specific iron uptake mutant of Neisseria meningitidis.
Microb. Pathog.
3:351-363[CrossRef][Medline].
|
| 21.
|
Gonzalez, G. C.,
D. L. Caamano, and A. B. Schryvers.
1990.
Identification and characterization of a porcine-specific transferrin receptor in Actinobacillus pleuropneumoniae.
Mol. Microbiol.
4:1173-1179[CrossRef][Medline].
|
| 22.
|
Gonzalez, G. C.,
R.-H. Yu,
P. R. Rosteck, and A. B. Schryvers.
1995.
Sequence, genetic analysis, and expression of Actinobacillus pleuropneumoniae transferrin receptor genes.
Microbiology
141:2405-2416[Abstract].
|
| 23.
|
Gray-Owen, S. D.,
S. Loosmore, and A. B. Schryvers.
1995.
Identification and characterization of genes encoding the human transferrin-binding proteins from Haemophilus influenzae.
Infect. Immun.
63:1201-1210[Abstract].
|
| 24.
|
Gray-Owen, S. D., and A. B. Schryvers.
1996.
Bacterial transferrin and lactoferrin receptors.
Trends Microbiol.
4:185-191[CrossRef][Medline].
|
| 25.
|
Haas, R., and T. F. Meyer.
1986.
The repertoire of silent pilus genes in Neisseria gonorrhoeae: evidence for gene conversion.
Cell
44:107-115[CrossRef][Medline].
|
| 26.
|
Hagblom, P.,
E. Segal,
E. Billyard, and M. So.
1985.
Intragenic recombination leads to pilus antigenic variation in Neisseria gonorrhoeae.
Nature
315:156-158[CrossRef][Medline].
|
| 27.
|
Heller, K. J.,
R. J. Kadner, and K. Gunther.
1988.
Suppression of the btuB451 mutation by mutations in the tonB gene suggests a direct interaction between TonB and TonB-dependent receptor proteins in the outer membrane of Escherichia coli.
Gene
64:147-153[CrossRef][Medline].
|
| 28.
|
Kadner, R. J.
1990.
Vitamin B12 transport in Escherichia coli: energy coupling between membranes.
Mol. Microbiol.
4:2027-2033[Medline].
|
| 29.
|
Kellogg, D. S., Jr.,
W. L. Peacock, Jr.,
W. E. Deacon,
L. Brown, and C. I. Pirkle.
1963.
Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation.
J. Bacteriol.
85:1274-1279[Abstract/Free Full Text].
|
| 30.
|
Klebba, P. E.,
J. M. Rutz,
J. Liu, and C. K. Murphy.
1993.
Mechanisms of TonB-catalyzed iron transport through the enteric bacterial cell envelope.
J. Bioenerg. Biomembr.
25:603-611[Medline].
|
| 31.
|
Koebnik, R., and V. Braun.
1993.
Insertion derivatives containing segments of up to 16 amino acids identify surface- and periplasm-exposed regions of the FhuA outer membrane receptor of Escherichia coli K-12.
J. Bacteriol.
175:826-839[Abstract/Free Full Text].
|
| 32.
|
Larsen, R. A.,
D. Foster-Hartnett,
M. A. McIntosh, and K. Postle.
1997.
Regions of Escherichia coli TonB and FepA proteins essential for in vivo physical interactions.
J. Bacteriol.
179:3213-3221[Abstract/Free Full Text].
|
| 33.
|
Lee, B. C., and A. B. Schryvers.
1988.
Specificity of the lactoferrin and transferrin receptors in Neisseria gonorrhoeae.
Mol. Microbiol.
2:827-829[CrossRef][Medline].
|
| 34.
|
Legrain, M.,
V. Mazarin,
S. W. Irwin,
B. Bouchon,
M.-J. Quentin-Millet,
E. Jacobs, and A. B. Schryvers.
1993.
Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2.
Gene
130:73-80[CrossRef][Medline].
|
| 35.
|
Lewis, L. A.,
E. Gray,
Y.-P. Wang,
B. A. Roe, and D. W. Dyer.
1997.
Molecular characterization of hpuAB, the haemoglobin-haptoglobin-utilization operon of Neisseria meningitidis.
Mol. Microbiol.
23:737-749[CrossRef][Medline].
|
| 36.
|
Lissolo, L.,
G. Maitre-Wilmotte,
P. Dumas,
M. Mignon,
D. Danve, and M.-J. Quentin-Millet.
1995.
Evaluation of transferrin-binding protein 2 within the transferrin-binding complex as a potential antigen for future meningococcal vaccines.
Infect. Immun.
63:884-890[Abstract].
|
| 37.
|
Locher, K. P.,
B. Rees,
R. Koebnik,
A. Mitschler,
L. Moulinier,
J. P. Rosenbusch, and D. Moras.
1998.
Transmembrane signaling across the ligand-gated FhuA receptor: crystal structures of free and ferrichrome-bound states reveal allosteric changes.
Cell
95:771-778[CrossRef][Medline].
|
| 38.
|
Loosmore, S. M.,
Y. P. Yang,
D. C. Coleman,
J. M. Shortreed,
D. M. England,
R. E. Harkness,
P. S. C. Chong, and M. H. Klein.
1996.
Cloning and expression of the Haemophilus influenzae transferrin receptor genes.
Mol. Microbiol.
19:575-586[CrossRef][Medline].
|
| 39.
|
Mickelsen, P. A.,
E. Blackman, and P. F. Sparling.
1982.
Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from lactoferrin.
Infect. Immun.
35:915-920[Abstract/Free Full Text].
|
| 40.
|
Mickelsen, P. A., and P. F. Sparling.
1981.
Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from transferrin and iron compounds.
Infect. Immun.
33:555-564[Abstract/Free Full Text].
|
| 41.
|
Murphy, C. K.,
V. I. Kalve, and P. E. Klebba.
1990.
Surface topology of the Escherichia coli K-12 ferric enterobactin receptor.
J. Bacteriol.
172:2736-2746[Abstract/Free Full Text].
|
| 42.
|
Myers, L. E.,
Y.-P. Yang,
R.-P. Du,
Q. Wang,
R. E. Harkness,
A. B. Schryvers,
M. H. Klein, and S. M. Loosmoore.
1998.
The transferrin-binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen.
Infect. Immun.
66:4183-4192[Abstract/Free Full Text].
|
| 43.
|
Neilands, J. B.
1982.
Microbial envelope proteins related to iron.
Annu. Rev. Microbiol.
36:285-309[CrossRef][Medline].
|
| 44.
|
Neilands, J. B.
1981.
Microbial iron compounds.
Annu. Rev. Biochem.
50:715-731[CrossRef][Medline].
|
| 45.
|
Newton, S. M. C.,
J. S. Allen,
Z. Cao,
Z. Qi,
X. Jiang,
C. Sprencel,
J. D. Igo,
S. B. Foster,
M. A. Payne, and P. E. Klebba.
1997.
Double mutagenesis of a positive charge cluster in the ligand-binding site of the ferric enterobactin receptor, FepA.
Proc. Natl. Acad. Sci. USA
94:4560-4565[Abstract/Free Full Text].
|
| 46.
|
Ogunnariwo, J. A.,
T. K. W. Woo,
R. Y. C. Lo,
G. C. Gonzalez, and A. B. Schryvers.
1997.
Characterization of the Pasteurella haemolytica transferrin receptor genes and the recombinant receptor proteins.
Microb. Pathog.
23:273-284[CrossRef][Medline].
|
| 47.
|
Pettersson, A.,
T. Prinz,
A. Umar,
J. van der Biezen, and J. Tommassen.
1998.
Molecular characterization of LbpB, the second lactoferrin-binding protein of Neisseria meningitidis.
Mol. Microbiol.
27:599-610[CrossRef][Medline].
|
| 48.
|
Postle, K.
1993.
TonB protein and energy transduction between membranes.
J. Bioenerg. Biomembr.
25:591-601[Medline].
|
| 49.
|
Rokbi, B.,
V. Mazarin,
G. Maitre-Wilmotte, and M.-J. Quentin-Millet.
1993.
Identification of two major families of transferrin receptors among Neisseria meningitidis strains based on antigenic and genomic features.
FEMS Microbiol. Lett.
110:51-58[CrossRef][Medline].
|
| 50.
|
Rokbi, B.,
M. Mignon,
G. Maitre-Wilmotte,
L. Lissolo,
B. Danve,
D. A. Caugant, and M.-J. Quentin-Millet.
1997.
Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains.
Infect. Immun.
65:55-63[Abstract].
|
| 51.
|
Schirmer, T.,
T. A. Keller,
Y.-F. Wang, and J. P. Rosenbusch.
1995.
Structural basis for sugar translocation through maltoporin channels at 3.1 Å resolution.
Science
267:512-514[Abstract/Free Full Text].
|
| 52.
|
Schoffler, H., and V. Braun.
1989.
Transport across the outer membrane of Escherichia coli K12 via the FhuA receptor is regulated by the TonB protein of the cytoplasmic membrane.
Mol. Gen. Genet.
217:378-383[CrossRef][Medline].
|
| 53.
|
Schramm, E.,
J. Mende,
V. Braun, and R. M. Kamp.
1987.
Nucleotide sequence of the colicin B activity gene cba: consensus peptapeptide among TonB-dependent colicins and receptors.
J. Bacteriol.
169:3350-3357[Abstract/Free Full Text].
|
| 54.
|
Stijilkovic, I.,
V. Hwa,
L. de Saint Martin,
P. O'Gaora,
X. Nassif,
F. Heffron, and M. So.
1995.
The Neisseria meningitidis haemoglobin receptor: its role in iron utilization and virulence.
Mol. Microbiol.
15:531-541[Medline].
|
| 55.
|
Weinberg, E. D.
1978.
Iron and infection.
Microbiol. Rev.
42:45-66[Free Full Text].
|
| 56.
|
West, S. E. H., and P. F. Sparling.
1987.
Aerobactin utilization by Neisseria gonorrhoeae and cloning of a genomic DNA fragment that complements Escherichia coli fhuB mutations.
J. Bacteriol.
169:3414-3421[Abstract/Free Full Text].
|
Infection and Immunity, August 2000, p. 4725-4735, Vol. 68, No. 8
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Noto, J. M., Cornelissen, C. N.
(2008). Identification of TbpA Residues Required for Transferrin-Iron Utilization by Neisseria gonorrhoeae. Infect. Immun.
76: 1960-1969
[Abstract]
[Full Text]
-
DeRocco, A. J., Cornelissen, C. N.
(2007). Identification of Transferrin-Binding Domains in TbpB Expressed by Neisseria gonorrhoeae. Infect. Immun.
75: 3220-3232
[Abstract]
[Full Text]
-
Sebaihia, M., Preston, A., Maskell, D. J., Kuzmiak, H., Connell, T. D., King, N. D., Orndorff, P. E., Miyamoto, D. M., Thomson, N. R., Harris, D., Goble, A., Lord, A., Murphy, L., Quail, M. A., Rutter, S., Squares, R., Squares, S., Woodward, J., Parkhill, J., Temple, L. M.
(2006). Comparison of the Genome Sequence of the Poultry Pathogen Bordetella avium with Those of B. bronchiseptica, B. pertussis, and B. parapertussis Reveals Extensive Diversity in Surface Structures Associated with Host Interaction.. J. Bacteriol.
188: 6002-6015
[Abstract]
[Full Text]
-
Ducey, T. F., Carson, M. B., Orvis, J., Stintzi, A. P., Dyer, D. W.
(2005). Identification of the Iron-Responsive Genes of Neisseria gonorrhoeae by Microarray Analysis in Defined Medium. J. Bacteriol.
187: 4865-4874
[Abstract]
[Full Text]
-
Price, G. A., Russell, M. W., Cornelissen, C. N.
(2005). Intranasal Administration of Recombinant Neisseria gonorrhoeae Transferrin Binding Proteins A and B Conjugated to the Cholera Toxin B Subunit Induces Systemic and Vaginal Antibodies in Mice. Infect. Immun.
73: 3945-3953
[Abstract]
[Full Text]
-
Agarwal, S., King, C. A., Klein, E. K., Soper, D. E., Rice, P. A., Wetzler, L. M., Genco, C. A.
(2005). The Gonococcal Fur-Regulated tbpA and tbpB Genes Are Expressed during Natural Mucosal Gonococcal Infection. Infect. Immun.
73: 4281-4287
[Abstract]
[Full Text]
-
van der Woude, M. W., Baumler, A. J.
(2004). Phase and Antigenic Variation in Bacteria. Clin. Microbiol. Rev.
17: 581-611
[Abstract]
[Full Text]
-
Yost-Daljev, M. K., Cornelissen, C. N.
(2004). Determination of Surface-Exposed, Functional Domains of Gonococcal Transferrin-Binding Protein A. Infect. Immun.
72: 1775-1785
[Abstract]
[Full Text]
-
Price, G. A., Hobbs, M. M., Cornelissen, C. N.
(2004). Immunogenicity of Gonococcal Transferrin Binding Proteins during Natural Infections. Infect. Immun.
72: 277-283
[Abstract]
[Full Text]
-
Sims, K. L., Schryvers, A. B.
(2003). Peptide-Peptide Interactions between Human Transferrin and Transferrin-Binding Protein B from Moraxellacatarrhalis. J. Bacteriol.
185: 2603-2610
[Abstract]
[Full Text]
-
Masri, H. P., Cornelissen, C. N.
(2002). Specific Ligand Binding Attributable to Individual Epitopes of Gonococcal Transferrin Binding Protein A. Infect. Immun.
70: 732-740
[Abstract]
[Full Text]
-
Boulton, I. C., Yost, M. K., Anderson, J. E., Cornelissen, C. N.
(2000). Identification of Discrete Domains within Gonococcal Transferrin-Binding Protein A That Are Necessary for Ligand Binding and Iron Uptake Functions. Infect. Immun.
68: 6988-6996
[Abstract]
[Full Text]